284 related articles for article (PubMed ID: 25039777)
21. A diselenide bond-containing ROS-responsive ruthenium nanoplatform delivers nerve growth factor for Alzheimer's disease management by repairing and promoting neuron regeneration.
Yuan X; Jia Z; Li J; Liu Y; Huang Y; Gong Y; Guo X; Chen X; Cen J; Liu J
J Mater Chem B; 2021 Sep; 9(37):7835-7847. PubMed ID: 34586144
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems.
Cunha S; Amaral MH; Lobo JM; Silva AC
Curr Med Chem; 2016; 23(31):3618-3631. PubMed ID: 27554805
[TBL] [Abstract][Full Text] [Related]
23. Advances in developing therapeutic strategies for Alzheimer's disease.
Nguyen TT; Nguyen TTD; Nguyen TKO; Vo TK; Vo VG
Biomed Pharmacother; 2021 Jul; 139():111623. PubMed ID: 33915504
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer's Disease: Innovative Therapeutic Approaches Based on Peptides and Nanoparticles.
Mota IFL; de Lima LS; Santana BM; Gobbo GAM; Bicca JVML; Azevedo JRM; Veras LG; Taveira RAA; Pinheiro GB; Mortari MR
Neuroscientist; 2023 Feb; 29(1):78-96. PubMed ID: 34018874
[TBL] [Abstract][Full Text] [Related]
25. Nanoformulated alpha-mangostin ameliorates Alzheimer's disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance.
Yao L; Gu X; Song Q; Wang X; Huang M; Hu M; Hou L; Kang T; Chen J; Chen H; Gao X
J Control Release; 2016 Mar; 226():1-14. PubMed ID: 26836197
[TBL] [Abstract][Full Text] [Related]
26. Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases.
Zhang L; Sun H; Chen Y; Wei M; Lee J; Li F; Ling D
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1696. PubMed ID: 33463089
[TBL] [Abstract][Full Text] [Related]
27. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management
Siafaka PI; Mutlu G; Okur NÜ
Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's disease and its treatment by different approaches: A review.
Srivastava S; Ahmad R; Khare SK
Eur J Med Chem; 2021 Apr; 216():113320. PubMed ID: 33652356
[TBL] [Abstract][Full Text] [Related]
29. Emerging nanotechnology for Alzheimer's disease: From detection to treatment.
Song N; Sun S; Chen K; Wang Y; Wang H; Meng J; Guo M; Zhang XD; Zhang R
J Control Release; 2023 Aug; 360():392-417. PubMed ID: 37414222
[TBL] [Abstract][Full Text] [Related]
30. Nanotechnologies for Alzheimer's disease: diagnosis, therapy, and safety issues.
Brambilla D; Le Droumaguet B; Nicolas J; Hashemi SH; Wu LP; Moghimi SM; Couvreur P; Andrieux K
Nanomedicine; 2011 Oct; 7(5):521-40. PubMed ID: 21477665
[TBL] [Abstract][Full Text] [Related]
31. Nanotechnology for Alzheimer Disease.
Leszek J; Md Ashraf G; Tse WH; Zhang J; Gasiorowski K; Avila-Rodriguez MF; Tarasov VV; Barreto GE; Klochkov SG; Bachurin SO; Aliev G
Curr Alzheimer Res; 2017; 14(11):1182-1189. PubMed ID: 28164767
[TBL] [Abstract][Full Text] [Related]
32. Amyloid β-targeted metal complexes for potential applications in Alzheimer's disease.
Liu H; Qu Y; Wang X
Future Med Chem; 2018 Mar; 10(6):679-701. PubMed ID: 29400551
[TBL] [Abstract][Full Text] [Related]
33. Neurotherapeutic applications of nanoparticles in Alzheimer's disease.
Sahni JK; Doggui S; Ali J; Baboota S; Dao L; Ramassamy C
J Control Release; 2011 Jun; 152(2):208-31. PubMed ID: 21134407
[TBL] [Abstract][Full Text] [Related]
34. Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020).
Binda A; Murano C; Rivolta I
Int J Nanomedicine; 2020; 15():6113-6135. PubMed ID: 32884267
[TBL] [Abstract][Full Text] [Related]
35. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
[TBL] [Abstract][Full Text] [Related]
36. Advancements in the Application of Nanomedicine in Alzheimer's Disease: A Therapeutic Perspective.
Puranik N; Yadav D; Song M
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762346
[TBL] [Abstract][Full Text] [Related]
37. The application of multifunctional nanomaterials in Alzheimer's disease: A potential theranostics strategy.
Xu Y; Zhao M; Zhou D; Zheng T; Zhang H
Biomed Pharmacother; 2021 May; 137():111360. PubMed ID: 33582451
[TBL] [Abstract][Full Text] [Related]
38. Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy.
Xi Y; Chen Y; Jin Y; Han G; Song M; Song T; Shi Y; Tao L; Huang Z; Zhou J; Ding Y; Zhang H
J Control Release; 2022 May; 345():38-61. PubMed ID: 35257810
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic nanotechnologies for Alzheimer's disease: A critical analysis of recent trends and findings.
Delbreil P; Rabanel JM; Banquy X; Brambilla D
Adv Drug Deliv Rev; 2022 Aug; 187():114397. PubMed ID: 35738546
[TBL] [Abstract][Full Text] [Related]
40. Nontoxic amphiphilic carbon dots as promising drug nanocarriers across the blood-brain barrier and inhibitors of β-amyloid.
Zhou Y; Liyanage PY; Devadoss D; Rios Guevara LR; Cheng L; Graham RM; Chand HS; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
Nanoscale; 2019 Nov; 11(46):22387-22397. PubMed ID: 31730144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
